[1]訾和平,杨晓荣,高貂艳.支气管哮喘儿童血清lncRNA KCNQ1OT1和FGF2水平表达对病情控制水平评估的价值[J].现代检验医学杂志,2025,40(02):169.[doi:10.3969/j.issn.1671-7414.2025.02.032]
　ZI Heping,YANG Xiaorong,GAO Diaoyan.Value of Serum lncRNA KCNQ1OT1 and FGF2 Levels in the Assessment of Disease Control in Children with Bronchial Asthma[J].Journal of Modern Laboratory Medicine,2025,40(02):169.[doi:10.3969/j.issn.1671-7414.2025.02.032]
点击复制

支气管哮喘儿童血清lncRNA KCNQ1OT1和FGF2水平表达对病情控制水平评估的价值()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第40卷
期数:
2025年02期
页码:
169
栏目:
论著
出版日期:
2025-03-15

文章信息/Info

Title:
Value of Serum lncRNA KCNQ1OT1 and FGF2 Levels in the Assessment of Disease Control in Children with Bronchial Asthma
文章编号:
1671-7414（2025）02-169-06
作者:
訾和平; 杨晓荣; 高貂艳
（榆林市中医医院儿科，陕西榆林 719000）
Author(s):
ZI Heping; YANG Xiaorong; GAO Diaoyan
(Department of Pediatrics，Yulin Hospital of Traditional Chinese Medicine，Shaanxi Yulin 719000，China)
关键词:
支气管哮喘; 非编码RNA; 钾电压门控通道亚家族Q 成员1 反向转录物1; 成纤维细胞生长因子2
分类号:
R562.25；R392.11
DOI:
10.3969/j.issn.1671-7414.2025.02.032
文献标志码:
A
摘要:
目的 探讨血清长链非编码RNA(lncRNA) 钾电压门控通道亚家族Q 成员1 反向转录物1（KCNQ1OT1）、成纤维细胞生长因子2（FGF2）在小儿支气管哮喘病情和控制水平评估中的价值。方法 选择2021 年3 月～ 2023 年3 月榆林市中医医院收治的96 例支气管哮喘患儿（哮喘组）和76 例健康儿童（对照组）。根据支气管哮喘病情将患儿分为轻度组（n=54）和重度组（n=42）；根据治疗后疾病控制情况将患儿分为哮喘控制组（n=61）和哮喘未控制组（n=35）。检测各组血清lncRNA KCNQ1OT1 和FGF2 水平，多因素Logistic 回归分析影响支气管哮喘疾病控制的因素；受试者工作特征（ROC）曲线评估lncRNA KCNQ1OT1 和FGF2 预测支气管哮喘疾病控制的效能。结果 哮喘组血清lncRNAKCNQ1OT1（2.35±0.71），FGF2（27.35±6.29 pg/ml）水平均高于对照组(1.51±0.33，15.32±4.08 pg/ml)，差异具有统计学意义（t=9.527，14.437，均P ＜ 0.001）。重度组血清lncRNA KCNQ1OT1（2.59±0.35），FGF2（28.65±1.03pg/ml）水平高于轻度组（2.16±0.41，26.34±1.24 pg/ml），差异具有统计学意义（t=5.429，9.737，均P ＜ 0.001）。哮喘未控制组血清lncRNA KCNQ1OT1（2.63±0.27），FGF2（29.02±1.41 pg/ml）高于哮喘控制组（2.19±0.35，26.39±1.52 pg/ml），差异具有统计学意义（t=6.417，8.374，均P ＜ 0.001）。高lncRNA KCNQ1OT1 和FGF2 水平是支气管哮喘患儿疾病未控制的危险因素（Wald χ2=8.792，5.638，均P ＜ 0.05）。lncRNA KCNQ1OT1，FGF2 联合预测支气管哮喘患儿疾病未控制的AUC（95%CI）高于单独预测，差异具有统计学意义（Z=3.250，2.096，均P ＜ 0.05）。结论 支气管哮喘患儿血清lncRNA KCNQ1OT1 和FGF2 均增高，与支气管哮喘病情加重和疾病未控制有关，联合lncRNA KCNQ1OT1 和FGF2 可预测支气管哮喘疾病控制水平。
Abstract:
Objective To explore the value of serum long non-coding RNA KCNQl opioid strand transcript 1 (lncRNA KCNQ1OT1) and fibroblast growth factor 2 (FGF2) in the evaluation of the condition and control level of pediatric bronchial asthma. Methods 96 children with bronchial asthma (Asthma group) and 76 healthy children (Control group) admitted to Yulin Hospital of Traditional Chinese Medicine from March 2021 to March 2023 were selected. According to the severity of bronchial asthma, the children were divided into a mild group (n=54) and a severe group (n=42). According to the disease control status after treatment, the children were divided into an asthma Control group (n=61) and an uncontrolled Asthma group (n=35). The serum levels of lncRNA KCNQ1OT1 and FGF2 were detected in each group. Multivariate Logistic regression analysis was performed to identify the factors affecting bronchial asthma disease control. The performance of lncRNA KCNQ1OT1 and FGF2 in predicting the control of bronchial asthma disease was evaluated using the receiver operating characteristic curve. Results The serum levels of lncRNA KCNQ1OT1 (2.35±0.71) and FGF2 (27.35±6.29 pg/ml) in the Asthma group were higher than those in the Control group(1.51±0.33，15.32±4.08 pg/ml)， and the differences were statistically significant (t=9.527, 14.437, all P < 0.001). The serum levels of lncRNA KCNQ1OT1 (2.59±0.35) and FGF2 (28.65±1.03 pg/ml) in the severe group were higher than those in the mild group（2.16±0.41，26.34±1.24 pg/ml）， and the differences were statistically significant (t=5.429, 9.737, all P < 0.001). The serum levels of lncRNA KCNQ1OT1 (2.63±0.27) and FGF2 (29.02±1.41 pg/ml) in the uncontrolled asthma group were higher than those in the controlled asthma group（2.19±0.35，26.39±1.52 pg/ml），and the differences were statistically significant (t=5.417, 8.374, all P < 0.001). High lncRNA KCNQ1OT1 and FGF2 levels were risk factors for uncontrolled disease in children with bronchial asthma (all P < 0.05). The AUC of lncRNA KCNQ1OT1 and FGF2 combined to predict uncontrolled disease in children with bronchial asthma , which was higher than of lncRNA KCNQ1OT1 and FGF2 alone， and the differences were statistically significant (Z=3.250, 2.096, all P < 0.05).Conclusion Serum lncRNA KCNQ1OT1 and FGF2 are both elevated in children with bronchial asthma, which is related to the worsening of bronchial asthma and uncontrolled disease. Combining lncRNA KCNQ1OT1 and FGF2 can predict the level of bronchial asthma disease control.

参考文献/References:

[1] 刘敏, 李承红, 刘双, 等. 诱导痰Galectin-3BP 及相关炎症因子水平检测在中性粒细胞型哮喘诊断中的价值[J]. 现代检验医学杂志,2020,35(6):56-58, 128. LIU Min, LI Chenghong, LIU Shuang, et al. Value of induced sputum galectin-3BP and related inflammatory factors in the diagnosis of neutrophil asthma[J]. Journal of Modern Laboratory Medicine, 2020, 35(6): 56-58, 128.
[2] ADAM-BONCI T I, CHERECHE?-PAN?A P, BONCI E A, et al. Suboptimal serum 25-hydroxy-vitamin D is associated with a history of recent disease exacerbation in pediatric patients with bronchial asthma or asthmasuggestive recurrent wheezing[J]. International Journal of Environmental Research and Public Health, 2020, 17(18): 6545.
[3] XIA Fangqi, WANG Yaqi, XUE Mengzhen, et al. LncRNA KCNQ1OT1: molecular mechanisms and pathogenic roles in human diseases [J]. Genes & Diseases, 2021, 9(6): 1556-1565.
[4] MOHAMMADIPOUR H S, FOROUZANFAR F, FOROUZANFAR A. The role of type 2 fibroblast growth factor in periodontal therapy[J]. Current Drug Targets, 2021, 22(3): 310-317.
[5] TAN Yuanyang, ZHOU Huiqin, LIN Yujing, et al. FGF2 is overexpressed in asthma and promotes airway inflammation through the FGFR/MAPK/NF-κB pathway in airway epithelial cells [J]. Military Medical Research, 2022, 9(1): 7.
[6] 中华医学会儿科学会呼吸学组,《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南[J].中华儿科杂志,2008,46(10):745-753. the Subspecialty Group of Respiratory Diseases,the Society of Pediatrics, Chinese Medical Association, the Editorial Board of Chinese Journal of Pediatrics. Guideline for the diagnosis and optimal management of asthma in children(2016) [J]. Chinese Journal of Pediatrics,2008,46(10):745-753.
[7] CORREN J, CASTRO M, JAYAWARDENA S, et al. Dupilumab improves asthma control and asthma-related quality of life in uncontrolled persistent asthma patients across all baseline exacerbation rates[J]. Chest, 2017, 152(4 Supplement): A26.
[8] 史宏磊, 黄克武. 支气管哮喘诊治年度进展2023[J].中华结核和呼吸杂志,2024,47(2):157-162. SHI Honglei, HUANG Kewu. Annual progress on bronchial asthma diagnosis and treatment in 2023 [J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2024, 47(2): 157-162.
[9] 李亚, 杨卫, 张红, 等. 血清炎症因子与支气管哮喘气道重构相关性的研究进展[J]. 医学综述,2023,29(8):1492-1496. LI Ya, YANG Wei, ZHANG Hong, et al. Research progress in relationship between serological indexes and airway remodeling in bronchial asthma [J]. Medical Recapitulate, 2023, 29(8): 1492-1496.
[10] YAN Xianpeng, LIU Hong, LI Ting. LncRNA NEAT1 regulates Th1/Th2 in pediatric asthma by targeting microRNA-217/GATA3 [J]. Iranian Journal of Public Health, 2023, 52(1): 106-117.
[11] TAHERI M, SHIRVANI-FARSANI Z, HARSIJ A, et al. A review on the role of KCNQ1OT1 lncRNA in human disorders [J]. Pathology - Research and Practice, 2024, 255: 155188.
[12] HE Sili, CHEN Yaling, CHEN Qihua, et al. LncRNA KCNQ1OT1 promotes the metastasis of ovarian cancer by increasing the methylation of EIF2B5 promoter[J].Molecular Medicine, 2022, 28(1): 112.
[13] WANG Furong, ZHANG Fucai, ZHENG Feng. lncRNA KCNQ1OT1 promotes bone formation by inhibiting miR-98-5p/Tbx5 axis in MC3T3-E1 cells[J]. Experimental and Therapeutic Medicine, 2022, 23(3): 194.
[14] YU Shijia, AN Jing, SUN Ran, et al. lncRNA KCNQ1OT1 predicts further cerebral events in patients with transient ischemic attack [J]. Frontiers in Pharmacology, 2022, 13: 961190.
[15] WANG Ping, ZHANG Haitao, ZHAO Weiqing, et al. Silencing of long non-coding RNA KCNQ1OT1 alleviates LPS-induced lung injury by regulating the miR-370-3p/FOXM1 axis in childhood pneumonia[J].BMC Pulmonary Medicine, 2021, 21(1): 247.
[16] YE Bozhi, WU Ziheng, TSUI T Y,et al. LncRNA KCNQ1OT1 suppresses the inflammation and proliferation of vascular smooth muscle cells through Iκba in intimal hyperplasia [J]. Molecular Therapy. Nucleic Acids, 2020, 20:62-72.
[17] THEOFANI E, SEMITEKOLOU M, SAMITAS K, et al. TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma[J]. Allergy, 2022, 77(7): 2131-2146.
[18] ZHANG Chunjian, GONG Yimeng, LI Na, et al. Long noncoding RNA KCNQ1OT1 promotes sC5b-9-induced podocyte pyroptosis by inhibiting miR-486a-3p and upregulating NLRP3[J]. American Journal of Physiology-Cell Physiology, 2021, 320(3): C355-C364.
[19] LIVINGSTON M J, SHU Shaoqun, FAN Ying, et al. Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis[J]. Autophagy, 2023, 19(1): 256-277.
[20] ZHUGE D L, JAVAID H M A, SAHAR N E, et al. Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation[J]. Archives of Pharmacal Research, 2020, 43(12): 1311-1324.
[21] 蒋婕, 邓亮, 王岭. 血清FGF2 表达水平与急性呼吸窘迫综合征患者病情严重程度及预后的关系[J]. 临床肺科杂志,2023,28(11):1662-1666. JIANG Jie, DENG Liang, WANG Ling. Relationship between serum FGF2 expression level and severity and prognosis of patients with acute respiratory distress syndrome [J]. Journal of Clinical Pulmonary Medicine, 2023, 28(11): 1662-1666.
[22] TAN Yuanyang, QIAO Yongkang, CHEN Zhuanggui, et al. FGF2, an immunomodulatory factor in asthma and chronic obstructive pulmonary disease (COPD) [J].Frontiers in Cell and Developmental Biology, 2020, 8: 223.

相似文献/References:

[1]吉翔,华芸,张学军.哮喘患儿血清白介素与免疫球蛋白检测的临床意义[J].现代检验医学杂志,2015,30(06):127.[doi:10.3969/j.issn.1671-7414.2015.06.039]
　JI Xiang,HUA Yun,ZHANG Xue-jun.Clinical Significance of Combined Detection of Serum Interleukin and Immune Globulin in Children with Asthma[J].Journal of Modern Laboratory Medicine,2015,30(02):127.[doi:10.3969/j.issn.1671-7414.2015.06.039]
[2]李 勇,高春彪,盛伟武,等.儿童支气管哮喘患者血浆中miRNA-125b及miRNA-133b的表达及临床意义[J].现代检验医学杂志,2017,32(03):59.[doi:10.3969/j.issn.1671-7414.2017.03.016]
　LI Yong,GAO Chun-biao,SHENG Wei-wu,et al.Expression and Its Significance of microRNA-125b and microRNA-133b in Plasma in Children with Asthma[J].Journal of Modern Laboratory Medicine,2017,32(02):59.[doi:10.3969/j.issn.1671-7414.2017.03.016]
[3]范艳平a,易甲其a,吴 敏b.支气管哮喘患儿血清MMP-9,Gal-3,TGF-β1与肺功能的关系研究[J].现代检验医学杂志,2017,32(04):76.[doi:10.3969/j.issn.1671-7414.2017.04.021]
　FAN Yan-pinga,YI Jia-qia,WU Minb.Relationship between Serum MMP-9,Gal-3,TGF-β1 and Pulmonary Function in Children with Bronchial Asthma[J].Journal of Modern Laboratory Medicine,2017,32(02):76.[doi:10.3969/j.issn.1671-7414.2017.04.021]
[4]赵含信,郝维敏.支气管哮喘并发幽门螺杆菌感染患儿粪便抗原与血清抗体特征分析[J].现代检验医学杂志,2019,34(01):72.[doi:10.3969/j.issn.1671-7414.2019.01.018]
　ZHAO Han-xin,HAO Wei-min.Characteristics of Stool Antigen and Serum Antibody in Children with Bronchial Asthma and Helicobacter Pylori Infection[J].Journal of Modern Laboratory Medicine,2019,34(02):72.[doi:10.3969/j.issn.1671-7414.2019.01.018]
[5]李晓刚a,邓巧妮a,王军焕a,等.儿童哮喘患者外周血 ILC2 细胞和 Th2 型细胞相关因子水平变化及与临床相关性研究[J].现代检验医学杂志,2020,35(06):72.[doi:doi:10.3969/j.issn.1671-7414.2020.06.018]
　LI Xiao-gang a,DENG Qiao-ni a,WANG Jun-huan a,et al.Changes of ILC2 Cells and Th2 Cell Related Factors in Peripheral Blood ofChildren with Asthma and Their Clinical Relevance[J].Journal of Modern Laboratory Medicine,2020,35(02):72.[doi:doi:10.3969/j.issn.1671-7414.2020.06.018]
[6]李　颖,任炳臣,韩晓庆,等.支气管哮喘患者血清MicroRNA-145水平表达与肺功能、气道重塑及Th1/Th2平衡的关系分析[J].现代检验医学杂志,2021,36(05):133.[doi:10.3969/j.issn.1671-7414.2021.05.030]
　LI Ying,REN Bing-chen,HAN Xiao-qing,et al.Relationship between Serum MicroRNA-145 Expression with Lung Function,Airway Remodeling and Th1/Th2 Balance in Patients with Bronchial Asthma[J].Journal of Modern Laboratory Medicine,2021,36(02):133.[doi:10.3969/j.issn.1671-7414.2021.05.030]
[7]蒋筠斐,须　静,钟政荣.支气管哮喘患者外周血TIM4，IgG4及EOS水平表达与其肺功能、哮喘发病严重程度及预后的相关性研究[J].现代检验医学杂志,2021,36(05):148.[doi:10.3969/j.issn.1671-7414.2021.05.033]
　JIANG Yun-fei,XU Jing,ZHONG Zheng-rong.Correlation of Peripheral Blood TIM4, IgG4 and EOS ExpressionLevels with the Prognosis in Bronchial Asthma Patients[J].Journal of Modern Laboratory Medicine,2021,36(02):148.[doi:10.3969/j.issn.1671-7414.2021.05.033]
[8]杨　怡,王永清,李　华.儿童支气管哮喘患者血清NETs和IL-4水平表达与发作期中医证型的相关性分析[J].现代检验医学杂志,2021,36(06):157.[doi:10.3969/j.issn.1671-7414.2021.06.034]
　YANG Yi,WANG Yong-qing,LI Hua.Correlation Analysis of Serum NETs, IL-4 Expression and TCM Syndromes in Children with Bronchial Asthma During Onset[J].Journal of Modern Laboratory Medicine,2021,36(02):157.[doi:10.3969/j.issn.1671-7414.2021.06.034]
[9]任婷婷,杨艳娥,马歆花,等.支气管哮喘急性期患儿血清VAMP2 水平表达及其临床意义[J].现代检验医学杂志,2023,38(05):175.[doi:10.3969/j.issn.1671-7414.2023.05.033]
　REN Tingting,YANG Yane,MA Xinhua,et al.Expression and Clinical Significance of Serum VAMP2 in Children with Bronchial Asthma at Acute Stage[J].Journal of Modern Laboratory Medicine,2023,38(02):175.[doi:10.3969/j.issn.1671-7414.2023.05.033]
[10]马慧敏,周晓静,卢东娥,等.支气管哮喘患儿RNase3基因多态性及其表达水平与气道炎症程度及糖皮质激素疗效的关系研究[J].现代检验医学杂志,2025,40(02):164.[doi:10.3969/j.issn.1671-7414.2025.02.031]
　MA Huimin,ZHOU Xiaojing,LU Donge,et al.Relationship between RNase3 Gene Polymorphism and Its Expression Level with Airway Inflammation and Glucocorticoid Efficacy in Children with Bronchial Asthma[J].Journal of Modern Laboratory Medicine,2025,40(02):164.[doi:10.3969/j.issn.1671-7414.2025.02.031]

备注/Memo

备注/Memo:
基金项目：陕西省卫生健康科研项目（2021D099）。
作者简介：訾和平（1979-），男，本科，副主任医师，研究方向：儿内科，E-mail：caihp125642@126.com。
通讯作者：高貂艳（1984-），女，本科，主治医师，研究方向：儿科，E-mail：18700251952@163.com。
更新日期/Last Update: 2025-03-15